Accountability
Material changes preserve what changed, why it changed, when it changed, and which evidence records were affected.
Public log
The entries below seed the correction history for claims carried over from the original prototype.
Removed protocol-like framing, dosing implications, and individualized biomarker thresholds. Proposed combinations now require a testable question, failure conditions, and explicit “site hypothesis” label.
CorrectedASTIS studied systemic sclerosis, not systemic lupus erythematosus. Any future SLE transplant summary must use disease-relevant evidence and preserve population and study-design limits.
CorrectedCross-study or mechanistic differences do not establish comparative clinical superiority. Cellular-therapy language now emphasizes small selected cohorts, limited comparisons, safety, and durability uncertainty.
CorrectedThe page no longer treats biological reprogramming findings as proof that EBV causes most lupus. Causal and subgroup questions are separated from established findings.
Clarified